Effect of semaglutide on weight loss and glycaemic control in patients with Prader-Willi Syndrome and type 2 diabetes

被引：5

作者：

Gimenez-Palop, Olga ^{[1
,2
]}

Romero, Ana ^{[1
]}

Casamitjana, Laia ^{[1
,2
]}

Pareja, Rocio ^{[1
,2
]}

Rigla, Mercedes ^{[1
,2
]}

Caixas, Assumpta ^{[1
,2
]}

机构：

[1] Univ Autonoma Barcelona, Hosp Univ Parc Tauli, Endocrinol & Nutr Dept, Corporacio Sanitaria Parc Tauli, Sabadell, Spain

[2] Univ Autonoma Barcelona, Dept Med, Bellaterra, Spain

来源：

ENDOCRINOLOGIA DIABETES Y NUTRICION | 2024年 / 71卷 / 02期

关键词：

Prader- Willi Syndrome; Diabetes mellitus; Semaglutide; Obesity; GLUCAGON-LIKE PEPTIDE-1; ADULTS;

D O I：

10.1016/j.endien.2023.12.001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Prader-Willi Syndrome (PWS) is the most common genetic cause of obesity, occurring in approximately 1 in 15,000 newborns. It results from the lack of expression of genes on the paternal allele of the chromosomal region 15q-11q13 (65-75% due to type 1 or type 2 deletion). Individuals with PWS experience associated symptoms such as hypotonia, hyperphagia, and early-onset obesity (before 5 years of age). Around 20% of adults with PWS also develop type 2 diabetes. Previous studies have shown the beneficial effects of GLP1-RA medications, such as exenatide and liraglutide, in treating type 2 diabetes in PWS. However, there is limited information available on the use of semaglutide in PWS. This study aimed to evaluate the effects of semaglutide on weight loss and glycaemic control in four patients with PWS and type 2 diabetes associated with obesity. The patients were started on weekly subcutaneous progressive doses of semaglutide. (c) 2024 SEEN y SED. Published by Elsevier Espana, S.L.U. All rights reserved.

引用

页码：83 / 87

页数：5

共 22 条

[11] Treatment with growth hormone in the prader-willi syndrome [J].

Moix Gil, Eugenia ;

Gimenez-Palop, Olga ;

Caixas, Assumpta .

ENDOCRINOLOGIA DIABETES Y NUTRICION, 2018, 65 (04) :229-236

[12] The effects of glucagon-like peptide (GLP)-1 receptor agonists on weight and glycaemic control in Prader-Willi syndrome: A systematic review [J].

Ng, Nicholas Beng Hui ;

Low, Yue Wey ;

Rajgor, Dimple Dayaram ;

Low, Jia Ming ;

Lim, Yvonne Yijuan ;

Loke, Kah Yin ;

Lee, Yung Seng .

CLINICAL ENDOCRINOLOGY, 2022, 96 (02) :144-154

[13]

Nordisk N., EMA approves liraglutide for teenagers with obesity

[14]

Nordisk N., 2020, FDA approves Saxenda for the treatment of obesity in adolescents aged 12-17

[15] A phase 3 randomized clinical trial using a once-weekly glucagon-like peptide-1 receptor agonist in adolescents and young adults with hypothalamic obesity [J].

Roth, Christian L. ;

Perez, Francisco A. ;

Whitlock, Kathryn B. ;

Elfers, Clinton ;

Yanovski, Jack A. ;

Shoemaker, Ashley H. ;

Abuzzahab, M. Jennifer .

DIABETES OBESITY & METABOLISM, 2021, 23 (02) :363-373

[16] Effects of Semaglutide on Glycemic Control and Weight Loss in a Patient with Prader-Willi Syndrome: A Case Report [J].

Sani, Elena ;

Da Prato, Giuliana ;

Zenti, Maria Grazia ;

Bordugo, Andrea ;

Trombetta, Maddalena ;

Bonora, Enzo .

ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2022, 22 (10) :1053-1057

[17] The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss [J].

Secher, Anna ;

Jelsing, Jacob ;

Baquero, Arian F. ;

Hecksher-Sorensen, Jacob ;

Cowley, Michael A. ;

Dalboge, Louise S. ;

Hansen, Gitte ;

Grove, Kevin L. ;

Pyke, Charles ;

Raun, Kirsten ;

Schaffer, Lauge ;

Tang-Christensen, Mads ;

Verma, Saurabh ;

Witgen, Brent M. ;

Vrang, Niels ;

Knudsen, Lotte Bjerre .

JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (10) :4473-4488

[18] The glucagon-like peptide-1 analog liraglutide suppresses ghrelin and controls diabetes in a patient with Prader-Willi syndrome [J].

Senda, Miho ;

Ogawa, Susumu ;

Nako, Kazuhiro ;

Okamura, Masashi ;

Sakamoto, Takuya ;

Ito, Sadayoshi .

ENDOCRINE JOURNAL, 2012, 59 (10) :889-894

[19] Physical Health Problems in Adults With Prader-Willi Syndrome [J].

Sinnema, Margje ;

Maaskant, Marian A. ;

Lantman-de Valk, Henny M. J. van Schrojenstein ;

van Nieuwpoort, I. Caroline ;

Drent, Madeleine L. ;

Curfs, Leopold M. G. ;

Schrander-Stumpel, Constance T. R. M. .

AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2011, 155A (09) :2112-2124

[20] Current and emerging therapies for managing hyperphagia and obesity in Prader-Willi syndrome: A narrative review [J].

Tan, Qiming ;

Orsso, Camila E. ;

Deehan, Edward C. ;

Triador, Lucila ;

Field, Catherine J. ;

Hein Min Tun ;

Han, Joan C. ;

Mueller, Timo D. ;

Haqq, Andrea M. .

OBESITY REVIEWS, 2020, 21 (05)

← 1 2 3 →